1. Phase II study of azacitidine with pembrolizumab in patients with intermediate‐1 or higher‐risk myelodysplastic syndrome. (2nd August 2021) Authors: Chien, Kelly S.; Kim, Kunhwa; Nogueras‐Gonzalez, Graciela M.; Borthakur, Gautam; Naqvi, Kiran; Daver, Naval G.; Montalban‐Bravo, Guillermo; Cortes, Jorge E.; DiNardo, Courtney D.; Jabbour, Elias; Alvarado, Yesid; Andreeff, Michael; Bose, Prithviraj; Jain, Nitin; Kadia, Tapan M.; Huang, Xuelin; Sh... Journal: British journal of haematology Issue: Volume 195:Number 3(2021) Page Start: 378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗